Abstract
Introduction
Regulation is the key in maintaining any complex phenomenon in an arrayed manner and human physiology is one of the best examples where gene expression is precisely controlled at cellular and tissue levels in temporal and conditional manners [1, 2] . From a therapeutic perspective, complete understanding of the regulatory mechanisms is indispensible for genomic medicine [2, 3] . A newly discovered method of regulation of biological functions by microRNAs (miRNAs), a ~22 nucleotide non-coding, endogenous and conserved RNAs has opened a new era of genomics called microRNomics [4, 5] . MiRNAs regulate protein expression primarily through base pairing at 3Ј untranslated region (UTR) of target mRNAs leading to mRNA cleavage or repression of the translational machinery for protein synthesis [6] . The binding specificity of miRNA to its target is presumably dictated by 6-7 nucleotide sequence from 5Ј region of miRNA, called 'seed' sequence [4] , which nucleates binding to target mRNA and allows more 3Ј region of miRNA for subsequent zippers up with the target mRNA [6] . The complimentarity of seed sequence to the target determines mRNA degradation or translational inhibition [4] . In the human genome nearly thousands of unique miRNAs are encoded, and they are predicted to regulate expressions of at least 30% of all human protein encoding genes thereby regulating almost all cellular functions [7, 8] . Here, it is germane to mention that a given miRNA is specific of a sequence and not of a single mRNA, and this is the reason that a single miRNA can modify expression of several mRNAs [9] . Some miRNAs are expressed in a tissue-specific manner [10] . For example mir-126 is endothelial specific [11] whereas miR-208 is cardiac specific [12] . There are approximately 50 miRNAs overexpressed in mouse heart [13] . Aberrant expressions of miRNAs in the heart lead to hypertrophy and other cardiac pathologies [14, 15] . The precise regulatory function of miRNAs is not restricted to the heart; rather it is involved in regulation of other organs like brain [16] , gonad [17] , dendritic cells [18] and many more.
The heart is the first organ formed during embryogenesis [19] . From embryogenesis to adult life, the heart is precisely regulated, and even a subtle perturbance in fine tuning of cardiac regulation causing either structural or functional remodelling leads to catastrophic consequences [20] . Despite our understanding about the biology of the heart, it is a leading cause of non-infectious infant mortality [21] , and primary cause of morbidity and mortality in the industrialized world [22] . Cardiovascular diseases (the wide spectrum of diseases that affect the heart or blood vessels) is one of the major causes of death worldwide accounting for nearly 17 
Biogenesis of miRNAs and their regulatory mechanisms
MiRNAs can be derived from individual miRNA genes, introns of protein coding genes or polycistronic transcripts [20] . They are transcribed by RNA polymerase II or III into primary miRNA (primiRNA), which are several kilobases long, capped (MGpppG) and polyadenylated [23] (Fig. 1) [24] . The pre-miRNAs are transported from the nucleus to the cytoplasm by RAN-GTPdependant nuclear export factor, exportin 5 [25, 26] [26] . If the 3Ј UTR of target sequence precisely matches the miRNA, Ago-2 will bind to the RISC complex, but if there are mismatches, Ago-1 will bind to the RISC [27] .
Mature miRNA binds to complementary sites in the target to negatively regulate gene expression in two ways depending on its complimentarity to target sequence: (1) if sequence at 3Ј UTR matches perfectly to target sequence, it will be cleaved and degraded by Ago2-RISC complex [28, 29] , and (2) if there is imperfect complimentarity, as in most situations in mammalian cells, it causes translational repression [30, 31] . However, few investigations revealed that even imperfect base pairing of miRNA with its target sequence can lead to a decreased abundance of the mRNA [32] . Although the prediction of target of a particular miRNA is mainly dependant on Watson-Crick seed pairing, this approach is unable to predict the functional mismatched target sites of miRNA, suggesting the need for a more advanced miRNA target prediction tool [33] .
MiRNAs in cardiovascular diseases
The profiling studies revealed a large number of miRNAs which are differentially expressed in heart failure pointing to the new mode of regulation of cardiovascular diseases [13] [14] [15] [31] [32] [33] [34] [31] , failed to induce cardiac phenotypes in transgenic mice [35] . On the other hand, knock down of miR-133 leads to cardiac hypertrophy [36] . The functional assay thus confirmed the role of several miRNAs in hypertrophy, fibrosis, arrhythmia, myocardial infarction (MI), heart failure and angiogenesis [11, 26, [37] [38] [39] (Fig. 2) .
MiRNAs in hypertrophy
Excessive cardiac workload leads to the enlargement of the heart (hypertrophy) in an endeavour to manage the increased [40] . Pathological hypertrophy is mainly caused due to hypertension, genetic polymorphisms and loss of myocytes following ischemic damage [41] . In addition to this, alterations in cardiac metabolism can also lead to hypertrophy [42] . Increase in the size of the heart develops in two ways: (1) concentric, which is caused by chronic pressure overload and leads to reduced left ventricular volume and increased wall thickness through addition of sarcomeres in parallel, and (2) eccentric that results due to volume overload and ultimately leads to dilation after thinning of the heart wall through addition of sarcomeres in series [43] . Hypertrophy is accompanied by an increase in the number of cardiac fibroblasts leading to fibrosis and myocyte loss. Myocyte loss leads to more workload [43] [45] . The role of miR-21 in hypertrophy is controversial [4] .
leading to enlargement of the heart and thus the vicious cycle of cardiac enlargement and myocyte loss continues causing heart failure. The whole process is regulated at fine level by different miRNAs such as miR-29, which is involved in fibrosis, and miR-133 and miR-195 which regulate the size of cardiomyocytes. Several miRNAs differentially expressed in cardiac hypertrophy [44] such as miR-1, miR-133, miR-29, miR-30 and miR-150 are down-regulated whereas miR-23a, miR-24, miR-125, miR-129, miR-195, miR-199, miR-208 and miR-212 are up-regulated
An interesting aspect of change in genetic profiling of miRNAs in failing heart is that it is reprogrammed as foetal genetic set up [46] which allows coordinated synthesis of proteins needed for increased myocyte size and adjustment to the altered energy demands of these larger cells [41] . [34] . Both miRNAs directly interact with 3Ј UTR of CTGF and down-regulate its expression, which is accompanied by decreased production of collagen [34] . These exciting results suggest the involvement of miRNAs in structural heart disease. Another interesting study involving miRNA profiling at different regions of the heart after MI revealed that miR-29 is dramatically down-regulated in boarder zone flanking the infracted area [39] . Therefore [47] .
MiRNAs in cardiac fibrosis

Ratio of collagen to elastin is crucial to maintain the extracellular matrix (ECM) in the heart. In failing heart, several structural remodelling occur, and one of them is the increase in matrix protein that enhances fibrosis. Connective tissue growth factor (CTGF), a key molecule involved in fibrosis, is shown to be regulated by two miRNAs: miR-133 and miR-30
MiRNAs in arrhythmia
Membrane excitability is a special feature of cardiomyocytes and it is maintained by ion channels, which are regulated by miRNA [4] . [48] . In another study, it has been found that miR-1-2 knockout mice that survived to adulthood shows abnormal propagation of cardiac electrical activity [37] . These mice show normal anatomy and functions but had slower heart rate, a shortened PR interval, and a broadened QRS complex, indicative of bundle branch block associated with sudden death [37] 
The three major intrinsic properties of cardiac excitability that are reflected through electric conductance of cardiac cells are automaticity (the measure of cells to generate spontaneous action potential), cardiac conduction (propagation of excitation within a cell and between cells) and membrane repolarization (property to determine the length of action potential and the effective refractory period) [48]. Arrhythmia is diagnosed with the help of electrocardiogram (ECG) which is composed of mainly PR interval and segment, QRS complex, QT interval, ST segment and the RR intervals. PR interval begins at the onset of the P wave and ends at the onset of QRS complex. PR segment represents the duration of the conduction from the atrioventricular node, down the bundle of His and through the bundle branches to the muscle. It detects atrioventricular blockade. The QRS complex begins at the Q wave and ends at the endpoint of the S wave. It represents the duration of ventricular depolarization. It diagnoses the aberrant conduction, ventricular ectopic beats, ventricular hypertrophy and electrolyte imbalance. The QT interval begins at the onset of the QRS complex and ends at the end point of the T wave. It reflects the duration from the depolarization to the repolarization of the ventricles. Although it varies with gender and age, it helps in detecting the ventricular ectopic beats and ventricular tachycardia. The ST segment begins at the end point of the S wave and ends at the onset of the T wave. It is normally isoelectric and represents the duration of relaxation of the atrial cells and contraction of ventricles. This segment diagnoses the myocardial ischemia because depression of ST
MiRNAs in myocardial infarction
The coronary artery supplies blood to the heart muscle and its occlusion leads to MI. MI is accompanied by a pathological remodelling response that includes hypertrophy and fibrosis, and is a major cause of morbidity and mortality in human beings [52] . [57] .
MiRNAs in heart failure
Due to hypertrophy and other pathological conditions, the heart cannot pump an adequate amount of blood to the body. This disease is called heart failure. In extensive miRNA profile of three human heart diseases -ischemic cardiomyopathy, DCM and aortic stenosis with the normal heart -it has been found that out of 87 miRNAs detected in the heart, 7 showed the same pattern of expression and more than half were differentially expressed in at least one disease group [31] . Interestingly, the miRNAs in foetal heart and failing heart expressed in similar patterns and this reprogramming of foetal pattern in the failing heart provides a clue to progression of heart failure [46] . [59, 60] . [64] . However, the first miRNA reported to be differentially expressed in diabetic heart is miR-133, and it plays key role in a long QT syndrome (LQTS) [65] and cardiac hypertrophy [36] . [67] . The role of miR-29 in both hyperglycemia and hyperinsulinemia [68] , and its association with cardiac fibrosis [39] tempted us to speculate that it may be another potential candidate for future studies in diabetic cardiomyopathy. [70] . 
MiRNAs in angiogenesis
MiRNAs in diabetic cardiomyopathy
Diabetes is a physiological condition where glucose level goes high due to defects in insulin production, secretion and its signalling [61]. Diabetes may be caused either due to self-destruction of the pancreatic ␤ cells (type 1 diabetes) or due to defects in insulin production or action (type 2 diabetes) [61]. Interestingly, both types of diabetes are associated with secondary complications and cardiac dysfunction is a most common manifestation of type 2 diabetes [61]. The pancreatic ␤-cells that produce insulin are regulated by miRNAs [62, 63] and particularly miR-375 that regulates insulin secretion negatively by targeting myotrophin [62]. Myotrophin acts as a transcriptional activator of NF-B in cardiomyocytes that is associated with cardiac hypertrophy
Mir-133 represses expression of human ether-a-go-go related gene that is associated with LQTS and encodes a cardiac potassium channel responsible for rapid delayed rectifier K ϩ current (IKr) [66]. Nevertheless, it is noteworthy that overexpression of miR-133 induces LQTS whereas down-regulation of miR-133 leads to cardiac hypertrophy in diabetic heart, and the significance of this intriguing regulation remains to be determined
MiRNAs in antherogenesis
Antherogenesis, also called atherosclerosis, is defined as a process of forming atheromas, plaques in the inner lining of arteries, and it has been established as a chronic inflammatory disease [69]. The low-density lipoprotein (LDL) when oxidized by oxygen free radicals (reactive oxygen species) and coming into contact with arterial wall, causes atherosclerotic lesions leading to increase in endothelial permeability and adhesiveness
Role of Dicer in cardiomyopathy
The fact that Dicer is biologically important for maturation of all miRNAs has been established in various cell types including embryonic stem cells [76] , germline cells [77] as well as specialized cell types, such as pancreatic islet cells [78] , immune cells [79] , neural cells [80] and endothelial cells [81] . [83] and endothelial cell function [81, 84] . Functional studies show that cardiac-specific knockout of Dicer leads to rapidly progressive DCM, heart failure and postnatal lethality [44] . The contractile proteins were misexpressed and there was profound sarcomeres disarray in Dicer mutant mice [44] . An important caveat is that Dicer expression decreased in end-stage human DCM and in failing heart but significantly increased in those hearts which were assisted with left ventricle assist devices to improve cardiac functions [44] [35] , cardiac and disease development [85] and the reprogramming of foetal gene expression during heart failure [46] point to the major involvement of miRNAs in heart diseases. The fact that overexpression of single miRNA, miR-195, can induce pathological cardiac hypertrophy and failure [35] indicates the power of individual miRNA in regulating the coordination of target genes involved in complex physiological and disease phenotypes. The most important difference between microRNomics and traditional approach of therapy is that traditional drugs have specific cellular targets whereas miRNAs modulate the entire functional network [86] .
MiRNAs -a new strategy for treatment of cardiovascular diseases
MiRNA -an innovative therapeutic approach
Despite tremendous efforts in the traditional approach to reduce mortality by heart disease, there is high rate of mortality and increasing number of morbidity. Therefore, it poses a great challenge to the therapeutic strategy adopted until now. In the traditional method of drug design involving enzymes, cell surface receptors might not bring much success in treatment of cardiovascular diseases due to the high sensitive nature of the heart. In this dismaying scenario, the discovery of an entirely new method of regulation by miRNAs, and their validation as markers and modulators of cardiac remodelling during pathological conditions engendered a new hope for innovative therapy. Recent investigations on the regulation of cellular response to stress
MiRNAs in stem cell therapy
MiRNAs are also involved in regulation of stem cell division [87] . The role of miRNA in regulating mesenchymal stem cell-derived neuronal cells [88] and in other cell functions has been documented [89] . Embryonic [91] . Although the success in transplantation of stem cells in the heart is promising and the delivery vectors for treatment of the heart is improving [92] , stem cell therapy still needs several improvements for translation from bench to bed side. A problem with mesenchymal stem cell engraftment was formation of bone and cartilage in the heart after transplantation [93] . The 
A new candidate in microRNomics
A distinct type of cell is reported in myocardium called interstitial Cajal-like cells (ICLC) [94, 95] which are speculated to be progenitor/stem cells in myocardium and are expected to be a therapeutic target of regenerative cardiovascular medicine [96] . Although the function of ICLC is yet to be established, their putative therapeutic potential will make them a promising candidate to be included in microRNomics.
Therapeutic challenges and their remedies
Since the first discovery of miRNA lin-4, which target lin-14 during temporal pattern formation in Caenorhabditis elegans [97] , and their use in genetic manipulation to silence mRNA by RNA interference [98] , a large number of miRNAs have been discovered that regulate cardiac functions. However, the major challenge in the functional studies of miRNAs is the fact that each miRNA has a large number of targets and each gene can also be regulated by several different miRNAs [99] . Additionally, the recent findings that miRNAs can also stimulate translation of mRNAs [100] and regulation of one miRNA by another [101] makes the understanding of functional aspects of miRNAs more complex. Nevertheless, the development of several tools for either to overexpress miRNAs in specific tissues [102] or to block the function of individual miRNAs [103, 104] [82] , and comparison of genetic profiles of foetal, adult and failing heart [46] [106] .
Mode of delivery of miRNAs
The mode of delivery of miRNAs will play significant role in therapy. For treatment of heart disease, which is entering phase II/III clinical trials, the major challenge is to improve the efficacy of gene delivery vectors to the target tissue [92] [92] . Although, the main safety concern with these vectors is their chances of homologous recombination producing wild type HIV [113] , designing of new lentivirus where U3 promoter region of the long terminal repeats are deleted (self inactivating lentivirus) resolved this issue [114] . The success in current form of lentivirus vector [115] [116] . From therapeutic point of view, creating the in vitro models that mimic the local milieu of the target tissue and pursuing experiments in that microenvironment to understand the ill effects of the gene/miRNA at in vivo condition will be of tremendous help to assess the tentative causes that impede the desired therapeutic outcome [116] . Additionally, this approach will increase the chances of success of the gene/drug/miRNA during clinical trial. Microenvironment has tremendous effect on the expression of apoptotic genes. Several miRNAs are involved in regulation of cell differentiation, proliferation and death [117] [118] [119] [120] [121] , and depending on the microenvironment some of them cause cell proliferation (cancer) even though they are involved in regulation of cell death (apoptosis) [122] . 
Role of microenvironment
MicroRNomics approach to cardiovascular therapy
